Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Syngene International Ltd.

Division of Biocon Ltd.
www.syngeneintl.com

Latest From Syngene International Ltd.

Biocon Biologics Eyes Sales Of $1bn

Strong growth in Biocon's biologics segment continued in the second quarter and the vertical has now set a target of $1bn in annual sales by the 2021-22 fiscal year.

Sales & Earnings Strategy

Biocon Biologics Eyes $1bn In Sales As Q2 Revenues Jump 40%

Strong growth in Biocon's biologics segment continued in the second quarter and the vertical has now set a target of $1bn in annual sales by the 2021-22 fiscal year.

India Biologics

Biocon Expects US Success For Biosimilar Trastuzumab Despite Amgen Launch

Leading Indian biologics firm Biocon reported first-quarter net profit soared more than 70% and said it is confident of a “very successful” US biosimilar trastuzumab launch, despite rival Amgen stealing a march by commercializing its own version first in the world’s largest drug market.

 

India Biosimilars

Deal Watch: Opportunity Knocks For Partnerships In Asia

ApolloBio signs on to take Inovio's HPV immunotherapy into China and Senju and Fosun sign China partnerships – all part of a wave of Chinese companies looking to bring innovative new medicines to the Greater China markets. Meanwhile, GSK signs on with Indian CRO Syngene.

Deals Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
  • Services
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Syngene International Pvt. Ltd.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • India
  • Parent & Subsidiaries
  • Biocon Ltd.
  • Senior Management
  • Jonathan Hunt, CEO
    M.B. Chinappa, Pres., Fin. & CFO
    Manoj Nerurkar, PhD, COO
  • Contact Info
  • Syngene International Ltd.
    Phone: (91)
    Bommasandra-Jigani Link Rd., Biocon Park
    Bangalore, 560 099
    India
UsernamePublicRestriction

Register